Oxygerolan (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxygerolan, is an opioid analgesic presented as a strength/form for oral use. It is prescribed for moderate to severe pain management in adult patients when other analgesics are insufficient.

GNH USA supplies Oxygerolan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxygerolan is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for: - Acute postoperative pain: provides effective relief following surgical procedures. - Cancer‑related pain: helps manage persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: used when pain is intense and other treatments have failed.

Oxygerolan may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: mild to moderate queasiness. - Drowsiness: increased sleepiness or sedation. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or addiction: potential for misuse. - Seizures: rare convulsive episodes. - Anaphylaxis: severe allergic reaction. - adrenal insufficiency: rare hormonal imbalance.

When prescribing Oxygerolan, clinicians should consider several safety measures: - Assess pain severity and prior opioid exposure: ensure appropriate indication. - Evaluate  ". - Evaluate  \

Potential ");